Business Context and Reporting Period
This Form 8-K Current Report was filed by TopSpin Medical, Inc. (not My Size, Inc.) on October 6, 2011. The registrant is incorporated in Delaware and maintains its principal executive offices in Bnei-Brak, Israel. The report discloses a material change in executive leadership.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or operational metrics.
Material Changes
- Executive Appointment: Hanan Waksman, 37, was appointed Chief Executive Officer (CEO) effective October 6, 2011.
- Executive Departure: Eitan Shtarkman ceased serving as CEO on October 6, 2011, having held the position since February 2011.
- Compensation Arrangement: Mr. Waksman entered into a consulting agreement with the Company.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. It details Mr. Waksman's professional background, including prior roles as a director for Rabintex and Travelfusion, Vice President of Capital International, and positions at Sage Capital Growth and PricewaterhouseCoopers. His compensation is set at 40,000 NIS (approximately $11,000) per month plus VAT.
Investor Verification Checklist
- Verify the exact terms of the consulting agreement between TopSpin Medical, Inc. and Hanan Waksman.
- Confirm the reason for Eitan Shtarkman's departure as CEO.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance data, as this 8-K contains none.
- Assess Mr. Waksman's prior experience in the medical technology sector versus his background in finance and real estate.